| 发明名称 |
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION |
| 摘要 |
The present invention refers to a pharmaceutical composition comprising (a) lixisenatide or/and a pharmaceutically acceptable salt thereof, and (b) insulin glargine or/and a pharmaceutically acceptable salt thereof, wherein the compound (b) and compound (a) are present in a fixed ratio. |
| 申请公布号 |
WO2014202483(A1) |
申请公布日期 |
2014.12.24 |
| 申请号 |
WO2014EP62418 |
申请日期 |
2014.06.13 |
| 申请人 |
SANOFI-AVENTIS DEUTSCHLAND GMBH |
发明人 |
SOUHAMI, ELISABETH;SILVESTRE, LOUISE |
| 分类号 |
A61K38/26;A61K38/28;A61P3/10 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
